Medicine recalls
|
| |
| The United States: Market Withdrawal: Calcium Chloride Intravenous Infusion 10% w/v – 10mL (Prefilled Syringe) |
| |
In April 2015, Mylan Institutional conducted a voluntary market withdrawal of 14 lots of Calcium Chloride Intravenous Infusion 10%w/v, packaged in 10 mL prefilled syringes (details of lot numbers involved can be found in the FDA's website). In June 2015, Mylan Institutional issued a second notification of the market withdrawal. Mylan has recently become aware that some units of this drug may still be on the market. The company urged health care providers to check their inventory and crash boxes, quarantine and discontinue distribution and use of these lots.
This market withdrawal was initiated as a precautionary measure due to the receipt of customer complaints citing difficulties in administration of the drug as a result of incompatibility between the syringe and certain needleless adaptors. The lots involved with this market withdrawal were distributed in the U.S. between March 19, 2014, and February 24, 2015. The Calcium Chloride product is packaged with an Agila and Amneal label. Amneal is a marketing partner with Agila for Calcium Chloride Intravenous Infusion 10%w/v, 10 mL prefilled syringes.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm454770.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Wednesday, July 15, 2015
Issued at HKT 13:00
|
| |
